The Critical Gap in Cannabis Evidence for Mental Health Conditions
The sparse evidence cannabis mental health research reveals highlights a significant gap in clinical knowledge. Clinicians currently lack sufficient data to guide psychiatric therapy involving cannabis. This gap underscores the urgent need for rigorous…
Cannabinoids for Pediatric Medicine: Clinical Evidence Review
Cannabinoids pediatric clinical evidence has been studied across many pediatric conditions. This review summarizes safety and efficacy data from hundreds of studies. Clinicians should carefully consider individual patient factors when evaluating…
Cannabinoid Study Depression Anxiety PTSD Insights
This article highlights a cannabinoid study depression anxiety PTSD research relevant to cannabis clinical practice. It compares cannabinoids with other treatments for mood disorders. The findings provide insights into therapeutic potential and safety…
How to Buy Weed in Israel: Medical Access, Decriminalization & the Tel Aviv Scene | Herb
Israel medical cannabis access has pioneered one of the world's most accessible legal markets. The country's regulatory framework supports both medical use and decriminalization. This approach informs global clinical research and patient care.
Want to Buy More Cannabis? Vermont Bill Could Change Purchase Limits
The Vermont cannabis purchase limits bill proposes to increase the amount adults can legally buy. Clinicians should understand these changes to guide patients on safe consumption. This policy shift affects access patterns and treatment planning.
Lowcountry Hemp Sellers Challenge DEA Enforcement Actions
Hemp-derived THC enforcement by the DEA has led to raids on Lowcountry hemp retailers, prompting legal challenges. These actions highlight federal uncertainty around hemp products. The lawsuit aims to clarify enforcement and protect hemp businesses.
From relationships to cannabis neuroscience: WWU’s podcast covers it – The Western Front
This article highlights cannabis neuroscience harm reduction as featured in WWU's podcast. It provides clinicians with evidence-based insights to counsel patients on safer cannabis use. Understanding neurobiological effects is key to effective harm…
DEA Admits Teen Cannabis Use Has Drastically Decreased Since 1995, Despite Dozens of …
The DEA admits legal cannabis isn't increasing youth use, highlighting a significant decline in adolescent cannabis consumption since 1995. This challenges common assumptions about legalization and youth behavior. Clinicians can use this data to inform…
PA State to Enforce Stricter Hemp and Cannabis Regulations
Pennsylvania hemp regulations are evolving to address safety concerns around unregulated cannabinoid products like Delta-8 and THCA. These changes aim to reduce patient exposure to untested compounds sold without medical oversight. Clinicians should…
Artelo Biosciences Advances Peripheral Cannabinoid Agonists for Glaucoma
Peripheral cannabinoid receptor agonists glaucoma research is advancing with promising synthetic compounds like ART12.11. These therapies aim to reduce intraocular pressure, a key factor in glaucoma management. Clinicians should monitor emerging data on…